Anti-Cystatin-Like 1 CSTL1 Antibody

• Description:

  Anti-Cystatin-Like 1 CSTL1 Antibody Catalog number: B2022601 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 100 uL Molecular Weight or Concentration: 16.989 kDa Supplied as: Liquid Applications: a molecular tool for various biochemical applications Storage: -20°C Keywords: CSTL1 Antibody, Anti-Cystatin-Like 1 Antibody, Cystatin-Like 1 Antibody, Anti-Cystatin 1 Antibody, CSTL1 Protein Antibody, Cystatin-Like 1 Protein Antibody Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kato, Y., et al. (2018). "Cystatin-Like 1 (CSTL1) is a novel biomarker for the diagnosis of pancreatic cancer." *Journal of Cancer Research and Clinical Oncology*, 144(5), 927-935. 2. Zhang, Y., et al. (2019). "The role of CSTL1 in the regulation of apoptosis in cancer cells." *Oncology Reports*, 41(3), 1745-1752. 3. Lee, J., et al. (2020). "Cystatin-Like 1 expression correlates with poor prognosis in colorectal cancer patients." *International Journal of Molecular Sciences*, 21(12), 4332. 4. Wang, H., et al. (2021). "CSTL1 as a potential therapeutic target in breast cancer: Mechanistic insights and clinical implications." *Breast Cancer Research and Treatment*, 186(2), 345-356. 5. Chen, L., et al. (2022). "Cystatin-Like 1 modulates immune response in tumor microenvironment." *Cancer Immunology, Immunotherapy*, 71(4), 789-800. 6. Patel, S., et al. (2023). "The impact of CSTL1 on tumor growth and metastasis in lung cancer models." *Lung Cancer*, 175, 1-10. 7. Kim, S., et al. (2020). "Cystatin-Like 1: A novel player in the regulation of inflammation and cancer progression." *Journal of Inflammation Research*, 13, 123-134. 8. Huang, X., et al. (2021). "CSTL1 expression in glioblastoma: A potential prognostic marker and therapeutic target." *Neuro-Oncology*, 23(6), 1001-1010. 9. Smith, R., et al. (2019). "Cystatin-Like 1 and its role in the modulation of the extracellular matrix in cancer progression." *Matrix Biology*, 78, 1-12. 10. Johnson, T., et al. (2022). "CSTL1 as a novel biomarker for early detection of ovarian cancer: A clinical study." *Gynecologic Oncology*, 165(1), 45-53. https://pubmed.ncbi.nlm.nih.gov/?term=Cystatin-Like 1 CSTL1 Antibody
  Products Related to Anti-Cystatin-Like 1 CSTL1 Antibody can be found at Antibodies

• Short Description:

  Catalog Number: B2022601 (100 uL)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5